Exogenous Surfactant Therapy for Pediatric Patients with Acute Respiratory Distress Syndrome

Exogenous surfactant administration is currently being tested in patients with the acute respiratory distress syndrome (ARDS). The results of the studies have varied because several factors may influence the host’s response to this therapy. This clinical pilot study was designed to evaluate the safe...

Full description

Bibliographic Details
Published in:	Canadian Respiratory Journal
Main Authors:	James F Lewis, Jasvinder S Dhillon, Ram N Singh, Craig C Johnson, Timothy C Frewen
Format:	Article
Language:	English
Published:	Wiley 1997-01-01
Online Access:	http://dx.doi.org/10.1155/1997/903459

Similar Items

Exogenous surfactant therapy in non-respiratory distress syndrome
by: A Greenough
Published: (1996-01-01)

Effects of Exogenous Surfactants on the Parameters of Blood Gas Composition in Neonatal Respiratory Distress Syndrome
by: S. A. Perepelitsa, et al.
Published: (2007-06-01)

Surfactant and respiratory distress syndrome
by: A D Milner
Published: (1996-01-01)

EXOGENOUS SURFACTANTS OF NATURAL ORIGIN IN THE TREATMENT OF RESPIRATORY DISTRESS SYNDROME - COMPARATIVE COMPOSITION, BIOPHYSICAL PROPERTIES AND CLINICAL EFFECTIVENESS
by: D.О. Dobryanskyy
Published: (2020-10-01)

Surfactant Apoprotein D in Preterm Neonates with Acute Respiratory Distress Syndrome
by: S. A. Perepelitsa, et al.
Published: (2009-10-01)

Surfactant Protein D Is a Biomarker of Acute Respiratory Distress Syndrome
by: V. V. Moroz, et al.
Published: (2013-08-01)

Use of Surfactant-BL in Adult Patients with Acute Respiratory Distress Syndrome
by: A. V. Vlasenko, et al.
Published: (2005-12-01)

Respiratory and Systemic Effects of LASSBio596 Plus Surfactant in Experimental Acute Respiratory Distress Syndrome
by: Johnatas Dutra Silva, et al.
Published: (2016-02-01)

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
by: Shengguang Wang, et al.
Published: (2021-06-01)

The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning
by: Mario Pezzi, et al.
Published: (2020-01-01)

Lung ultrasound to guide the administration of exogenous pulmonary surfactant in respiratory distress syndrome of newborn infants: A retrospective investigation study
by: Jing Liu, et al.
Published: (2022-10-01)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
by: Mandy Brasher, et al.
Published: (2021-06-01)

Exogenous surfactant in the late respiratory phase of COVID-19
by: K. G. Shapovalov, et al.
Published: (2021-06-01)

Significance of surfactant proteins in respiratory distress syndrome in preterm infants
by: İ.A. Mirzayeva, et al.
Published: (2024-04-01)

Surfactant Protein D Is Altered in Experimental Malaria-Associated Acute Lung Injury/Acute Respiratory Distress Syndrome
by: Chuchard Punsawad, et al.
Published: (2019-01-01)

ABO Blood Type and Pediatric Acute Respiratory Distress Syndrome
by: Sema Yılmaz, et al.
Published: (2021-04-01)

Mechanical power and normalized mechanical power in pediatric acute respiratory distress syndrome
by: Farhan A. R. Shaikh, et al.
Published: (2024-01-01)

Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond
by: Ozge Sürmeli-Onay, et al.
Published: (2012-06-01)

The Effects of Antenatal Corticosteroids and Surfactant Replacement on Neonatal Respiratory Distress Syndrome
by: Suada Heljić, et al.
Published: (2009-08-01)

Surfactant Protein A (SP-A) is a Prognostic Molecular Biomarker in Acute Respiratory Distress Syndrome
by: V. V. Moroz, et al.
Published: (2013-06-01)

Efficiency of Combined Use of a Surfactant and the «Lung Opening» Maneuver in the Treatment of Acute Respiratory Distress Syndrome
by: A. V. Vlasenko, et al.
Published: (2007-06-01)

Effects of Xuanbai Chengqi decoction on lung compliance for patients with exogenous pulmonary acute respiratory distress syndrome
by: Mao ZR, et al.
Published: (2016-02-01)

PEDIATRIC ACUTE RESPIRATORY DISTRESS SYNDROME: PRACTICAL ASPECTS OF INTENSIVE THERAPY
by: YU.V. BYKOV, et al.
Published: (2024-06-01)

Comparison of Minimally Invasive Surfactant Therapy and Intubation-surfactant Administration-extubation in Premature Neonates with Respiratory Distress Syndrome
by: Mehrdad Rezaei, et al.
Published: (2025-03-01)

Comparison of the Consequences of Intratracheal Administration of Surfactant Plus Budesonide with Surfactant alone in Preterm Infants with Respiratory Distress Syndrome
by: Morteza Habibi, et al.
Published: (2024-01-01)

Effects of Two Different Exogenous Surfactant Preparations on Serial Peripheral Perfusion Index and Tissue Carbon Monoxide Measurements in Preterm Infants with Severe Respiratory Distress Syndrome
by: Demet Terek, et al.
Published: (2015-08-01)

Effects of Two Different Exogenous Surfactant Preparations on Serial Peripheral Perfusion Index and Tissue Carbon Monoxide Measurements in Preterm Infants with Severe Respiratory Distress Syndrome
by: Mei-Jy Jeng
Published: (2015-08-01)

Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants?
by: Christos Tsakalidis, et al.
Published: (2012-08-01)

Surfactant protein B gene polymorphism in preterm babies with respiratory distress syndrome
by: P.P.R. Lyra, et al.
Published: (2011-01-01)

Surfactant Therapy for Respiratory Distress Syndrome in High- and Ultra-High-Altitude Settings
by: Xudong Duan, et al.
Published: (2022-03-01)

Irrational prescription of surfactant replacement therapy in neonatal respiratory distress
by: Nader Jahanmehr, et al.
Published: (2022-01-01)

Irrational prescription of surfactant replacement therapy in neonatal respiratory distress.
by: Nader Jahanmehr, et al.
Published: (2022-01-01)

Prehospital administration of surfactant to a premature neonate in respiratory distress
by: Charles Haviland Mize, et al.
Published: (2019-10-01)

Inflammatory and tissue injury marker dynamics in pediatric acute respiratory distress syndrome
by: Nadir Yehya, et al.
Published: (2024-05-01)

Safety and efficacy of pulmonary surfactant therapy for acute respiratory distress syndrome in children: a systematic review and meta-analysis
by: Xuesong Ren, et al.
Published: (2025-05-01)

Comparison of the Efficacy of Three Natural Surfactants in Preterm Turkish Newborns with Respiratory Distress Syndrome
by: Fatma Hilal Yılmaz, et al.
Published: (2021-06-01)

Replacement Therapy with the Surfactant Alveofact for Neonatal Respiratory Distress Syndrome: A Pilot Study
by: S. A. Perepelitsa
Published: (2014-08-01)

Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome
by: Nilgün Köksal, et al.
Published: (2009-12-01)

Early versus late extubation after surfactant replacement therapy for respiratory distress syndrome
by: Mohamed Garib, et al.
Published: (2015-03-01)

Comparison of LISA and INSURE Methods in Surfactant Application in Preterm Babies with Respiratory Distress Syndrome
by: Neşet Aydın, et al.
Published: (2021-04-01)